Linked here is a detailed quantitative analysis of Amgen, Inc. (AMGN). Below are some highlights from the above linked analysis: Company Description: Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.
The company's debt to total capital of 92% (down from 98%) is well above my 45% maximum, and its free cash flow payout of 61% (up from 51%) is slightly above my 60% maximum. The stock is currently trading near my calculated fair value of $236.10. AMGN earned one Star in the Fair Value section, earned one Star in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of three Stars. This quantitatively ranks AMGN as a...
Source: Dividend Growth Stocks
Related Articles:
Dividend Growth Stocks News
- My Forever Portfolio: 5 Spectacular Dividend Stocks You Can Buy Now and Hold Forever - Nasdaq - 5/29/2025
- 2 High-Yield Canadian Dividend Stocks for Income Investors - Yahoo - 5/31/2025
- The Smartest Dividend Stocks to Buy With $2,000 Right Now - MSN - 5/30/2025
- Dividend Stocks To Keep An Eye On - May 28th - MarketBeat - 5/30/2025
- Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows. - MSN - 5/30/2025
- Genuine Parts Company (GPC) Dividend Stock Analysis - 5/30/2025
- AFLAC Incorporated (AFL) Dividend Stock Analysis - 5/23/2025
- Automatic Data Processing Inc. (ADP) Dividend Stock Analysis - 5/16/2025
- Air Products and Chemicals Inc. (APD) Dividend Stock Analysis - 5/9/2025
- Waste Management, Inc. (WM) Dividend Stock Analysis - 5/2/2025
Amgen, Inc. (AMGN) Dividend Stock Analysis
Posted by D4L | Wednesday, July 26, 2023 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.